* Allscripts Healthcare Solutions Inc MDRX.OQ MDRX.O is
expected to show a fall in quarterly revenue when it reports
results on February 24.
* The Chicago Illinois-based company is expected to report
a
5.6% decrease in revenue to $391.1 million from $414.5 million a
year ago, according to the mean estimate from 8 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Allscripts
Healthcare
Solutions Inc is for earnings of 32 cents per share. For the
same quarter last year, the company reported earnings of 29
cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Allscripts
Healthcare Solutions Inc is $20, about 0.4% below its last
closing price of $20.08.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 0.18 0.18 0.27 Beat 47.3
Jun. 30 2021 0.18 0.17 0.23 Beat 31.9
Mar. 31 2021 0.15 0.15 0.19 Beat 23.5
Dec. 31 2020 0.22 0.21 0.29 Beat 36.6
Sep. 0.19 0.19 0.20 Beat 5.6
30 2020
Jun. 30 2020 0.12 0.12 0.18 Beat 49.3
Mar. 31 2020 0.14 0.15 0.09 Missed -39.4
Dec. 31 2019 0.18 0.18 0.17 Missed -7
This summary was machine generated February 23 at 03:03 GMT.
All figures in US dollars unless otherwise stated